Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134:136–51.
Article
CAS
PubMed
Google Scholar
Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650–9.
Article
CAS
PubMed
Google Scholar
Haddow A. Molecular repair, wound healing, and carcinogenesis: tumor production a possible overhealing? Adv Cancer Res. 1972;16:181–234.
Article
CAS
PubMed
Google Scholar
Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, et al. Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res. 2006;66:7216–24.
Article
CAS
PubMed
Google Scholar
Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010;35:496–504.
Article
CAS
PubMed
Google Scholar
Vancheri C. Common pathways in idiopathic pulmonary fibrosis and cancer. Eur Respir Rev. 2013;22:265–72.
Article
PubMed
Google Scholar
Tomassetti S, Gurioli C, Ryu JH, Decker PA, Ravaglia C, Tantalocco P, et al. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. Chest. 2015;147:157–64.
Article
PubMed
Google Scholar
Sanders YY, Kumbla P, Hagood JS. Enhanced myofibroblastic differentiation and survival in Thy-1(−) lung fibroblasts. Am J Respir Cell Mol Biol. 2007;36:226–35.
Article
CAS
PubMed
Google Scholar
Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, Siegal GP, et al. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008;39:610–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, et al. Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One. 2012;7:e33770.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hojo S, Fujita J, Yamadori I, Kamei T, Yoshinouchi T, Ohtsuki Y, et al. Heterogeneous point mutations of the p53 gene in pulmonary fibrosis. Eur Respir J. 1998;12:1404–8.
Article
CAS
PubMed
Google Scholar
Uematsu K, Yoshimura A, Gemma A, Mochimaru H, Hosoya Y, Kunugi S, et al. Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis. Cancer Res. 2001;61:8527–233.
CAS
PubMed
Google Scholar
Demopoulos K, Arvanitis DA, Vassilakis DA, Siafakas NM, Spandidos DA. MYCL1, FHIT, SPARC, P16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis. J Cell Mol Med. 2002;6:215–22.
Article
CAS
PubMed
Google Scholar
Vassilakis DA, Sourvinos G, Spandidos DA, Siafakas NM, Bouros D. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2000;162:1115–9.
Article
CAS
PubMed
Google Scholar
Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med. 2008;178:729–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Leon AD, Cronkhite JT, Katzenstein AL, Godwin JD, Raghu G, Glazer CS, et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One. 2010;5:e10680.
Article
Google Scholar
Antoniou KM, Samara KD, Lasithiotaki I, Margaritopoulos GA, Soufla G, Lambiri I, et al. Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer. Oncolog Rep. 2013;30:2617–24.
CAS
Google Scholar
Ang S, Banerjee S, de Freitas A, Sanders YY, Ding Q, Matalon S, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012;180:484–93.
Article
Google Scholar
Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol. 2011;45:287–94.
Article
CAS
PubMed
Google Scholar
Yamada M, Kubo H, Ota C, Takahashi T, Tando Y, Suzuki T, et al. The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells. Respir Res. 2013;14:95.
Article
PubMed
PubMed Central
Google Scholar
Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K, et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibro-blasts: implication in epithelial-mesenchymal interactions. PLoS One. 2009;4:e6718.
Article
PubMed
PubMed Central
Google Scholar
Oak SR, Murray L, Herath A, Sleeman M, Anderson I, Joshi AD, et al. A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS One. 2011;6:e21253.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;182:220–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kojima T, Spray DC, Kokai Y, Chiba H, Mochizuki Y, Sawada N. Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line. Exp Cell Res. 2002;276:40–51.
Article
CAS
PubMed
Google Scholar
Koval M, Billaud M, Straub AC, Johnstone SR, Zarbock A, Duling BR, et al. Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43. Am J Pathol. 2011;178:2536–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mori R, Power KT, Wang CM, Martin P, Becker DL. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci. 2006;119:5193–203.
Article
CAS
PubMed
Google Scholar
Trovato-Salinaro A, Trovato-Salinaro E, Failla M, Mastruzzo C, Tomaselli V, Gili E, et al. Altered intercellular communication in lung fibroblast culture from patients with IPF. Respir Res. 2006;7:122.
Article
PubMed
PubMed Central
Google Scholar
Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc. 2006;3:377–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta: potential role in idiopathic pulmonary fibrosis. Am J Pathol. 2005;166:1321–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A. 2006;103:13180–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol. 2008;130:481–94.
Article
PubMed
PubMed Central
Google Scholar
Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc. 2006;3:364–72.
Article
CAS
PubMed
Google Scholar
Andersson-Sjöland A, de Alba CG, Nihlberg K, Becerril C, Ramírez R, Pardo A, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol. 2008;40:2129–40.
Article
PubMed
Google Scholar
Dancer RC, Wood AM, Thickett DR. Metalloproteinases in idiopathic pulmonary fibrosis. Eur Respir J. 2011;38:1461–7.
Article
CAS
PubMed
Google Scholar
Niki T, Kohno T, Iba S, Moriya Y, Takahashi Y, Saito M, et al. Frequent colocalization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am J Pathol. 2002;160:1129–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol. 2005;37:1787–804.
Article
CAS
PubMed
Google Scholar
Chilosi M, Zamò A, Doglioni C, Reghellin D, Lestani M, Montagna L, et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res. 2006;7:95.
Article
PubMed
PubMed Central
Google Scholar
Mazieres J, He B, You L, Xu Z, Jablons DM. Wnt signaling in lung cancer. Cancer Lett. 2005;222:1–10.
Article
CAS
PubMed
Google Scholar
Chilosi M, Poletti V, Zamò A, Lestani M, Montagna L, Piccoli P, et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol. 2003;162:1495–502.
Article
CAS
PubMed
PubMed Central
Google Scholar
Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N, et al. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblast into myofibroblasts. Pharmacol Res. 2008;57:274–82.
Article
CAS
PubMed
Google Scholar
Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655–7.
Article
CAS
PubMed
Google Scholar
Conte E, Gili E, Fruciano M, Korfei M, Fagone E, Iemmolo M, et al. PI3K p110g overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition. Lab Invest. 2013;93:566–76.
Article
CAS
PubMed
Google Scholar
Wei X, Han J, Chen ZZ, Qi BW, Wang GC, Ma YH, et al. A phosphoinositide 3-kinasegamma inhibitor, AS605240 prevents bleomycin-induced pulmonary fibrosis in rats. Biochem Biophys Res Commun. 2010;397:311–7.
Article
CAS
PubMed
Google Scholar
Bao Z, Zhang Q, Wan H, He P, Zhou X, Zhou M. Expression of suppressor of cytokine signaling 1 in the peripheral blood of patients with idiopathic pulmonary fibrosis. Chin Med J. 2014;127:2117–20.
CAS
PubMed
Google Scholar
Beyer C, Distler JH. Tyrosine kinase signaling in fibrotic disorders: translation of basic research to human disease. Biochim Biophys Acta. 2013;1832:897–904.
Article
CAS
PubMed
Google Scholar
Chaudhary NI, Roth GJ, Hilberg F, Müller-Quernheim J, Prasse A, Zissel G, et al. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J. 2007;29:976–85.
Article
CAS
PubMed
Google Scholar
Vuorinen K, Gao F, Oury TD, Kinnula VL, Myllarniemi M. Imatinibmesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia. Exp Lung Res. 2007;33:357–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR. Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results. Am J Respir Crit Care Med. 2010;181:604–10.
Article
CAS
PubMed
Google Scholar
Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011;65:1079–87.
Article
Google Scholar
Brown KKRL, Costabel U, Flaherty KR, Kim D, Noble PW, Raghu G, et al. Treatment of IPF with the tyrosine kinase inhibitor bibf 1120: Patient-reported outcomes in the tomorrow trial. Am J Respir Crit Care Med. 2012;185:A3634.
Article
Google Scholar
Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071–82.
Article
PubMed
Google Scholar
King Jr TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083–92. Erratum in. N Engl J Med. 2014;371(12):1172. doi:10.1056/NEJMoa1402582.
Article
Google Scholar
Teixeira MR, Heim S. Cytogenetic analysis of tumor clonality. Adv Cancer Res. 2011;112:127–49.
Article
CAS
PubMed
Google Scholar
Kotiligam D, Lazar AJ, Pollock RE, Lev D. Desmoid tumor: a disease opportune for molecular insights. Histol Histopathol. 2008;23:117–26.
CAS
PubMed
Google Scholar
Shah AA, Barfield ME, Kelsey CR, Onaitis MW, Tong B, Harpole D, et al. Outcomes after surgical management of synchronous bilateral primary lung cancers. Cancers Ann Thorac Surg. 2012;93:1055–60.
Article
PubMed
Google Scholar
Trousse D, Barlesi F, Loundou A, Tasei AM, Doddoli C, Giudicelli R, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg. 2007;133:1193–200.
Article
PubMed
Google Scholar
Kwast AB, Liu L, Roukema JA, Voogd AC, Jobsen JJ, Coebergh JW, et al. Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. Br J Cancer. 2012;107(3):549–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shuch B, Singer EA, Bratslavsky G. The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. Urol Clin North Am. 2012;39:133–48.
Article
PubMed
Google Scholar